These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6990089)

  • 1. Effect of a heptapeptide angiotensin analog on aldosterone secretion in the rabbit.
    Neusy AJ; Pessah M; Steele JM; Lowenstein J
    Kidney Int; 1980 Jan; 17(1):66-73. PubMed ID: 6990089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (7-Ile) angiotensin III: a relatively selective antagonist of angiotensin steroidogenesis.
    Campbell WB; Schmitz JM
    Eur J Pharmacol; 1979 Mar; 54(3):209-16. PubMed ID: 218823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.
    Kono T; Ikeda F; Taniguchi A; Imura H; Oseko F; Yoshioka M; Khosla MC
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):249-53. PubMed ID: 2990133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin III on blood pressure, renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Suzuki S; Doi Y; Aoi W; Kuramochi M; Hashiba K
    Jpn Heart J; 1984 Jan; 25(1):75-85. PubMed ID: 6376863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like?
    Braley LM; Menachery AI; Underwood RH; Williams GH
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T; Ikeda F; Oseko F; Nanno M; Imura H; Endo J
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):359-66. PubMed ID: 580136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB; Schmitz JM; Itskovitz HD
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem hydrochloride on pressor and steroidogenic actions of angiotensins and norepinephrine in man.
    Ikeda F; Kono T; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1980 Dec; 27(6):779-84. PubMed ID: 7262036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T; Oseko F; Ikeda F; Nanno M; Endo J
    J Clin Endocrinol Metab; 1976 Oct; 43(4):940-3. PubMed ID: 977730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective pharmacological effects of triprolyl and pentasarcosyl angiotensin II.
    Mikami H; Ogihara T; Katahira K; Imai N; Kumahara Y; Bumpus FM; Khosla MC
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):242-5. PubMed ID: 2436006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are angiotensin receptors in vascular smooth muscles a homogeneous population?
    Tabrizchi R; Pang CC
    Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens.
    Saye J; Binder SB; Trachte GJ; Peach MJ
    Endocrinology; 1986 Nov; 119(5):1895-903. PubMed ID: 3464412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide antagonists of angiotensin-induced adrenal catecholamine release.
    Ackerly JA; Sarstedt CA; Peach MJ
    Eur J Pharmacol; 1977 Apr; 42(4):391-401. PubMed ID: 856615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q; Zhang J; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1996 Aug; 118(7):1653-8. PubMed ID: 8842428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.